Showing results (71-80 of 193) with videos related to
Sort By:
Pageof 20
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|January 23, 1998
Biomechanical considerations of mandibular lengthening and widening by gradual distraction using a computer modelM L Samchukov, J B Cope, R P Harper, et al.Current Opinion in Pediatrics|August 16, 2020
Prevention of adverse drug effects: a pharmacogenomic approachErika N Scott, Jafar S Hasbullah, Bruce C Carleton, et al.Sexually Transmitted Infections|July 21, 2001
Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotypeM Shahmanesh, H Jaleel, Y DeSilva, et al.Physical Therapy|August 3, 2013
Promoting neuroplasticity for motor rehabilitation after stroke: considering the effects of aerobic exercise and genetic variation on brain-derived neurotrophic factorCameron S Mang, Kristin L Campbell, Colin J D Ross, et al.The Pharmacogenomics Journal|October 26, 2016
The global spectrum of protein-coding pharmacogenomic diversityG E B Wright, B Carleton, M R Hayden, et al.Paediatric Drugs|March 27, 2013
Cancer pharmacogenomics in children: research initiatives and progress to dateShahrad Rod Rassekh, Colin J D Ross, Bruce C Carleton, et al.International Journal of Sports Medicine|October 1, 1989
Muscle carnitine level in endurance training and running a marathonG M Janssen, H R Scholte, M H Vaandrager-Verduin, et al.Bioinformatics (Oxford, England)|June 23, 2018
HUME: large-scale detection of causal genetic factors of adverse drug reactionsMehrdad Mansouri, Bowei Yuan, Colin J D Ross, et al.Genitourinary Medicine|December 1, 1995
Why do patients default from follow-up at a genitourinary clinic?: a multivariate analysisJ D Ross, A McIver, A Blakely, et al.Drug Safety|March 14, 2024
The Role of Pharmacogenomics in Rare DiseasesAlice Man, Gabriella S S Groeneweg, Colin J D Ross, et al.Pageof 20